Protalix Biotherapeutics Inc. (PLX)
NYSE · Healthcare
Protalix Biotherapeutics Inc. Gross Margin 2009–2025
Current and historical gross margin for Protalix Biotherapeutics Inc. (PLX) over the last 10 years. The current gross profit margin for Protalix Biotherapeutics Inc. as of December 31, 2025 is 48.82%.
From: 12/31/2009To: 12/31/2025
Revenue
Gross Profit
Gross Margin
Protalix Biotherapeutics Inc. Gross Margin — FAQ
Protalix Biotherapeutics Inc. (PLX) gross margin over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Protalix Biotherapeutics Inc.'s gross margin?
Protalix Biotherapeutics Inc. (PLX) reported gross margin of 48.8% for fiscal 2025.
Where can I see PLX's gross margin history?
The chart and table above show Protalix Biotherapeutics Inc.'s gross margin by year and by quarter, including the growth rate.